CCL2 and pulmonary arterial hypertension: In another study, CCL2 serum levels were found to be significantly elevated both in the lcSSc and in the dcSSc subsets, but when considering lcSSc patients no association was detected with PAH, although a trend for CCL2 reduction was reported after treatment with bosentan or prostacyclin analogues [166].